133 related articles for article (PubMed ID: 15076939)
1. Visual outcomes and complications after multiple vitrectomies for diabetic vitreous hemorrhage.
Cooper B; Shah GK; Grand MG; Bakal J; Sharma S
Retina; 2004 Feb; 24(1):19-22. PubMed ID: 15076939
[TBL] [Abstract][Full Text] [Related]
2. Peripheral retinal cryotherapy for postvitrectomy diabetic vitreous hemorrhage in phakic eyes.
Neely KA; Scroggs MW; McCuen BW
Am J Ophthalmol; 1998 Jul; 126(1):82-90. PubMed ID: 9683153
[TBL] [Abstract][Full Text] [Related]
3. Early vitrectomy and endolaser photocoagulation in patients with type I diabetes with severe vitreous hemorrhage.
Chaudhry NA; Lim ES; Saito Y; Mieler WF; Liggett PE; Filatov V
Ophthalmology; 1995 Aug; 102(8):1164-9. PubMed ID: 9097742
[TBL] [Abstract][Full Text] [Related]
4. Reasons for and management of postvitrectomy vitreous hemorrhage in proliferative diabetic retinopathy.
Yan H; Cui J; Lu Y; Yu J; Chen S; Xu Y
Curr Eye Res; 2010 Apr; 35(4):308-13. PubMed ID: 20373898
[TBL] [Abstract][Full Text] [Related]
5. Role of intravitreal bevacizumab (Avastin) injected at the end of diabetic vitrectomy in preventing postoperative recurrent vitreous hemorrhage.
Cheema RA; Mushtaq J; Al-Khars W; Al-Askar E; Cheema MA
Retina; 2010; 30(10):1646-50. PubMed ID: 20634777
[TBL] [Abstract][Full Text] [Related]
6. Role of Tamponade in Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage.
Balakrishnan D; Jain B; Nayaka A; Rani PK; Mukundaprasad V; Jalali S
Semin Ophthalmol; 2017; 32(4):488-491. PubMed ID: 27128601
[TBL] [Abstract][Full Text] [Related]
7. Long-term results, prognostic factors and cataract surgery after diabetic vitrectomy: a 10-year follow-up study.
Ostri C; Lux A; Lund-Andersen H; la Cour M
Acta Ophthalmol; 2014 Sep; 92(6):571-6. PubMed ID: 24373516
[TBL] [Abstract][Full Text] [Related]
8. Long-term results of vitreous surgery for proliferative diabetic retinopathy.
Sima P; Zoran T
Doc Ophthalmol; 1994; 87(3):223-32. PubMed ID: 7835192
[TBL] [Abstract][Full Text] [Related]
9. Vitrectomy for complications of proliferative diabetic retinopathy. Functional outcomes.
Smiddy WE; Feuer W; Irvine WD; Flynn HW; Blankenship GW
Ophthalmology; 1995 Nov; 102(11):1688-95. PubMed ID: 9098263
[TBL] [Abstract][Full Text] [Related]
10. Visual outcomes and incidence of recurrent vitreous hemorrhage after vitrectomy in diabetic eyes pretreated with bevacizumab (avastin).
Lo WR; Kim SJ; Aaberg TM; Bergstrom C; Srivastava SK; Yan J; Martin DF; Hubbard GB
Retina; 2009; 29(7):926-31. PubMed ID: 19584650
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulation and clinically significant postoperative vitreous hemorrhage in diabetic vitrectomy.
Brown JS; Mahmoud TH
Retina; 2011 Nov; 31(10):1983-7. PubMed ID: 21836531
[TBL] [Abstract][Full Text] [Related]
12. Long-term visual and retinopathy outcomes in a predominately type 2 diabetic patient population undergoing early vitrectomy and endolaser for severe vitreous haemorrhage.
Ratnarajan G; Mellington F; Saldanha M; de Silva SR; Benjamin L
Eye (Lond); 2011 Jun; 25(6):704-8; quiz 709. PubMed ID: 21494282
[TBL] [Abstract][Full Text] [Related]
13. Vitreous hemorrhage after the 25-gauge transconjunctival sutureless vitrectomy for proliferative diabetic retinopathy.
Lee BJ; Yu HG
Retina; 2010; 30(10):1671-7. PubMed ID: 21060273
[TBL] [Abstract][Full Text] [Related]
14. Visual Outcomes after Vitrectomy for Terson Syndrome Secondary to Traumatic Brain Injury.
Narayanan R; Taylor SC; Nayaka A; Deshpande R; St Aubin D; Hrisomalos FN; Hu J; Rajagopal R; Tewari A; Apte RS
Ophthalmology; 2017 Jan; 124(1):118-122. PubMed ID: 27817917
[TBL] [Abstract][Full Text] [Related]
15. [Value of different measurements of the preoperative visual acuity and perception of Purkinje's vessel shadows for prediction of the postoperative visual acuity after vitrectomy in diabetic vitreous hemorrhage].
Schulze S; Köhler K; Schüller C
Klin Monbl Augenheilkd; 2006 Apr; 223(4):321-5. PubMed ID: 16639671
[TBL] [Abstract][Full Text] [Related]
16. Use of 10-Hz flash visual evoked potentials in prediction of final visual acuity in diabetic eyes with vitreous hemorrhage.
Vadrevu VL; Cavender S; Odom JV
Doc Ophthalmol; 1992; 79(4):371-82. PubMed ID: 1633747
[TBL] [Abstract][Full Text] [Related]
17. Transconjunctival anterior retinal cryotherapy for proliferative diabetic retinopathy.
Benedett R; Olk RJ; Arribas NP; Okun E; Johnston GP; Boniuk I; Escoffery RF; Grand MG; Schoch LH
Ophthalmology; 1987 Jun; 94(6):612-9. PubMed ID: 2442689
[TBL] [Abstract][Full Text] [Related]
18. Preoperative electroretinogram and postoperative visual outcome in patients with diabetic vitreous hemorrhage.
Hiraiwa T; Horio N; Terasaki H; Suzuki T; Yamamoto E; Horiguchi M; Miyake Y
Jpn J Ophthalmol; 2003; 47(3):307-11. PubMed ID: 12782170
[TBL] [Abstract][Full Text] [Related]
19. Visual outcome and risk factors for light perception and no light perception vision after vitrectomy for diabetic retinopathy.
Mason JO; Colagross CT; Haleman T; Fuller JJ; White MF; Feist RM; Emond TL; McGwin G
Am J Ophthalmol; 2005 Aug; 140(2):231-5. PubMed ID: 15992755
[TBL] [Abstract][Full Text] [Related]
20. Preoperative injection of intravitreal bevacizumab in dense diabetic vitreous hemorrhage.
Farahvash MS; Majidi AR; Roohipoor R; Ghassemi F
Retina; 2011; 31(7):1254-60. PubMed ID: 21499192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
